Here are 1-3 brief analogies for WW International (WW):

• Peloton for diet and healthy living: Like Peloton provides subscription-based fitness programs and community, WW offers subscription-based weight management programs and community support, focusing on holistic healthy living rather than just exercise equipment.
• Headspace for your eating habits: Similar to how Headspace provides guided meditation and mindfulness through a subscription, WW offers a guided program to build healthy eating habits and a positive mindset around food and wellness.
• Talkspace for weight and wellness coaching: Much like Talkspace connects users with therapists via a subscription for mental health support, WW connects its members with coaches and a community through a digital platform for weight management and wellness guidance.

• Digital Subscription: Provides access to a personalized weight management program through a mobile app and website, featuring food and activity tracking, recipes, and progress tools.
• Workshop + Digital Subscription: Offers the digital program alongside live group coaching sessions, led by a WW Coach, available both virtually and in-person.
• WeightWatchers Clinic: A telehealth service providing medical weight management, including prescriptions for weight-loss medications, complemented by integrated behavioral support.

WW International (symbol: WW) primarily sells its services directly to individuals, not to other companies. While they have a B2B arm (WeightWatchers Health Solutions) that partners with employers and health plans, this segment represents a minor portion of their total revenue (approximately 4% in 2023).

Therefore, WW serves primarily individual customers, which can be categorized as:

1. Individuals aiming for significant weight loss: This represents a core demographic of subscribers who join WW's programs with the explicit goal of achieving a specific weight reduction through structured dietary guidance, activity tracking, and behavioral support.

2. Individuals focused on weight maintenance and healthy living: This category includes members who have reached their target weight and utilize WW's tools for ongoing maintenance, as well as those primarily seeking to adopt sustainable healthy eating habits and improve overall wellness without a specific weight loss target.

3. Individuals managing chronic health conditions (e.g., Type 2 Diabetes): With the expansion into clinical services and specialized programs, WW attracts individuals who are looking for structured dietary and lifestyle support as part of their broader management plan for conditions like Type 2 Diabetes, often in conjunction with medical advice.

Tara Comonte, President and Chief Executive Officer

Ms. Comonte has served as President and Chief Executive Officer since February 2025, having previously been Interim President and Chief Executive Officer from September 2024 to February 2025. She possesses over two decades of executive leadership experience spanning corporate and digital strategy, technology, operations, and finance. Prior to her role at WW International, Ms. Comonte served as CEO of TMRW Life Sciences and held the positions of President and CFO at Shake Shack. She is also a board member for Kindbody and Strava.

Felicia DellaFortuna, Chief Financial Officer

Ms. DellaFortuna was appointed Chief Financial Officer, effective January 1, 2025. She previously held the CFO position at Enthusiast Gaming and BuzzFeed. During her tenure at BuzzFeed, she was instrumental in the acquisitions of Complex Networks and HuffPost and diversified revenue streams. Ms. DellaFortuna began her career at Ernst & Young in Transaction Advisory Services and Audit.

Michael Amsel, Chief Marketing Officer

Mr. Amsel has served as the Chief Marketing Officer since 2025. Before joining WeightWatchers, he was Senior Vice President of Growth, Marketing & Acquisition at Sirius XM Holdings Inc. from December 2021 to March 2025. He also served as Senior Vice President of Growth, Performance & CRM from December 2019 to December 2021 at Sirius XM, and Vice President of Growth at Pandora Media, Inc. from May 2018 to December 2019. Additionally, Mr. Amsel was the Senior Vice President of Marketing and General Manager at Bankrate from November 2017 to May 2018.

Alejandro Bethlen, Executive Vice President, International

Mr. Bethlen has served as Executive Vice President, International, since September 2025.

Jon Volkmann, Chief Operations Officer

Mr. Volkmann has served as Chief Operations Officer since June 2025, overseeing operations for the clinical business, field organization, and in-person community offerings. Previously, he was Chief Operating Officer at Weekend Health, the company that launched and operated Sequence, where he played a key role in scaling clinical, pharmacy, member support, and people operations. He joined WeightWatchers following the acquisition of Weekend Health in April 2023.

The key risks to WW International (symbol: WW) are primarily driven by the evolving weight management landscape and the company's financial position:

1. Competition from GLP-1 Weight Loss Drugs and Declining Behavioral Subscribers: The most significant risk stems from the rapid rise and popularity of GLP-1 (glucagon-like peptide-1) weight loss medications, such as Ozempic, Wegovy, and Mounjaro. These drugs offer a highly effective and often faster alternative to traditional diet and behavior-based weight management programs, directly impacting WW International's core business model. The company has experienced a decline in its "Behavioral" subscribers, a trend that is expected to continue. While WW is attempting to pivot into the clinical space by offering access to these medications, this shift is a challenging transition and introduces new complexities in its business strategy.
2. High Debt Load and Financial Instability: WW International carries a substantial debt burden, estimated at around $1.5 billion in long-term debt as of fiscal year 2023. This high leverage significantly strains the company's cash flow, as a considerable portion of its earnings must be allocated to interest payments. Reports indicate that the company utilized all available funds from its revolving credit facility, signaling financial distress, and S&P Global downgraded WW International's rating due to an elevated risk of default. In May 2025, WW International filed for a "pre-packaged" Chapter 11 bankruptcy to eliminate a significant portion of its debt, from which it later emerged.
3. Intensifying Competitive Landscape and Shifting Consumer Preferences: Beyond the direct threat of GLP-1 drugs, WW International faces broad competition from numerous other weight loss and wellness companies, including digital-first platforms like Noom and MyFitnessPal, and traditional programs such as Nutrisystem. The market is also subject to potential disruption from large technology companies like Apple and Google entering the wellness sector. Furthermore, there is an ongoing shift in consumer preferences towards newer brands and diverse weight loss methods, and WW's brand appears to be losing favor, particularly among younger demographics.

The primary clear emerging threat to WW International (WW) is the rapid rise and adoption of GLP-1 agonists (e.g., Ozempic, Wegovy, Mounjaro, Zepbound) and other advanced pharmaceutical interventions for weight loss.

These prescription medications offer a different and, for many individuals, significantly more effective pathway to achieving substantial weight loss compared to traditional behavioral and lifestyle modification programs. The strong efficacy and growing availability of these drugs present a fundamental challenge to WW's long-standing business model, which historically relies on sustained engagement with its dietary programs, coaching, and community support.

As more individuals turn to medical solutions for weight management, the demand for WW's core offerings could diminish or require a significant strategic pivot to integrate or compete with these pharmaceutical options, as evidenced by WW's recent acquisition of Sequence.

WW International (symbol: WW) operates within the broader weight management and obesity management markets, offering a range of products and services, including digital subscription products, personalized weight management programs, in-person workshops, coaching, community support, and branded products. They also provide tools and approaches for individuals taking GLP-1 medications or living with diabetes.

Addressable Markets for WW International's Main Products and Services:

• Global Weight Management Market: The global weight management market was valued at approximately USD 232.4 billion in 2023 and is anticipated to reach around USD 483.8 billion by 2032, growing at a CAGR of about 8.6% from 2024 to 2032. Other estimates place the global market size at USD 296.8 billion in 2024, projected to reach USD 572.4 billion by 2033. Another report indicated the market was valued at USD 591.7 billion in 2025, with projections to reach USD 906.0 billion by 2034.
• U.S. Weight Management Market: The U.S. weight loss and obesity management market was valued at USD 87 billion in 2023 and is anticipated to grow at a CAGR of 8.2% through 2032. Another report estimated the U.S. market at USD 37.86 billion in 2023, with a projection to reach USD 76.9 billion by 2030. Additionally, the U.S. weight loss and obesity management market is expected to be valued at US$5.5 billion in 2025 and reach US$7.5 billion by 2032.
• Global Digital Weight Loss / Online Weight Loss Programs Market: The global digital weight loss market, including digital weight loss solution vendors like WW International, is projected to reach over US$3 billion globally by 2025. More broadly, the global online weight loss programs market size was USD 105,365.2 million (approximately USD 105.37 billion) in 2024 and is expected to expand at a CAGR of 6.20% from 2024 to 2031. Another estimate states the global online weight loss programs market size was USD 2.23 billion in 2024, projected to reach USD 3.82 billion by 2033.
• U.S. Digital Health for Obesity Market: The U.S. digital health for obesity market size was estimated at USD 14.76 billion in 2024 and is predicted to be worth around USD 110.07 billion by 2034.
• Global Obesity Management Market: The global obesity management market was valued at $140.3 billion in 2023 and is projected to reach $351.8 billion by 2033, growing at a CAGR of 9.8% from 2024 to 2033. Another report valued the global obesity treatment market at USD 15.92 billion in 2024, projected to reach USD 60.53 billion by 2030.

1. Expansion of the Clinical Business and GLP-1 Integration: WW International is strategically focusing on and expanding its clinical business, which includes its telehealth services and the integration of medically-supported weight management solutions, particularly those involving GLP-1 medications. This segment has shown significant year-over-year revenue growth (e.g., 35% in Q3 2025 for clinical revenue) and is seen as a key area for future demand and diversification. The company has successfully transitioned a notable percentage of members from compounded to branded or oral GLP-1 medications.
2. Increase in Average Revenue Per User (ARPU) Driven by Clinical Subscribers: A key driver of revenue growth, even amidst overall subscriber declines, is the increasing average revenue per user (ARPU). This growth is primarily fueled by a strategic shift towards clinical subscribers, who generate significantly higher ARPU (nearly 5x that of behavioral subscribers). This trend is expected to continue as the clinical business expands.
3. Innovation and Stabilization of the Core Behavioral and Digital Business: Despite challenges in subscriber retention within the behavioral segment, WW International is focused on stabilizing this core business through disciplined execution and meaningful innovation in its digital and member experience. Efforts include enhancing the digital platform and launching new programs, such as the menopause program, to attract and retain members in the evolving weight management landscape.
4. Growth in the Business-to-Business (B2B) Channel: WW International has identified and is actively pursuing the expansion of its B2B channel as a strategic priority for long-term growth. This involves broadening its market reach beyond direct-to-consumer models.
5. Development and Launch of New Health Programs: The company is committed to developing new health programs, such as women's health initiatives, to diversify its offerings and cater to broader wellness needs. These new product and service launches are anticipated to contribute to future revenue growth by attracting new customer segments and enhancing existing member engagement.

Share Repurchases

• WW International made no share repurchases during fiscal 2023 and fiscal 2022.
• As of the end of fiscal 2023, $208.9 million remained authorized for future share repurchases under the existing program.

Share Issuance

• Following a financial reorganization and emergence from Chapter 11 in June 2025, existing shareholders received 9% of the new common equity of the reorganized company.
• Former lenders and noteholders of the company received 91% of the new common equity as part of the reorganization in June 2025.
• The number of issued shares of successor common stock was 9,987 thousand as of September 30, 2025, significantly reduced from 130,048 thousand predecessor shares issued as of December 28, 2024.

Outbound Investments

• In April 2023, WW International completed the acquisition of Weekend Health, Inc., operating as Sequence, a telehealth platform specializing in chronic weight management.
• The company acquired Denross Limited for $4,500 in December 2021.